RxDoctor Payments Data

Mary Ransom, MD

Neurology · Richmond, VANPI 1487697389

Payments from drug & device makers

$12,399in general payments, 2019–2025

Across 631 payments — averaging $19.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • UCB, Inc.$1K
  • Biogen$885
  • AbbVie$808
  • SK Life Science, Inc.$720
  • Sanofi$697
  • plus $7K from 54 others

What the payments were for

  • Speaking & faculty fees$610%
  • Food & beverage$12,338100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis93$1,205
UCB, Inc.52$1,090
Biogen47$885
AbbVie(2 entities)77$808
SK Life Science, Inc.18$720
Sanofi32$697
AstraZeneca(2 entities)23$608
Greenwich Biosciences, Inc.22$514
Kyowa Kirin, Inc.10$437
EMD Serono, Inc.25$401
Sunovion Pharmaceuticals Inc.19$401
Eisai Inc.17$314
Genentech USA, Inc.15$307
Amgen13$305
Teva Pharmaceuticals USA, Inc.15$266
Insightec,inc2$214
Biohaven Pharmaceuticals, Inc.9$189
Adamas Pharmaceuticals, Inc.5$187
Mallinckrodt Hospital Products Inc.8$179
Lilly USA, LLC11$172
Neurelis, Inc.6$162
Amneal Pharmaceuticals LLC10$154
CSL Behring7$139
Livanova USA, Inc.7$139
Lundbeck LLC7$133
MDD US Operations, LLC8$131
W. L. Gore & Associates, Inc.1$125
Avanir Pharmaceuticals, Inc.6$121
ANI Pharmaceuticals, Inc.1$116
Banner Life Sciences, LLC5$109
Bristol Myers Squibb6$95
Supernus Pharmaceuticals, Inc.5$86
TG Therapeutics, Inc.1$86
Acadia Pharmaceuticals Inc4$81
GE HealthCare3$73
Johnson & Johnson3$73
Biohaven Pharmaceutical Holding Company Ltd.3$70
Acorda Therapeutics, Inc4$61
Grifols USA, LLC3$52
Alnylam Pharmaceuticals Inc.2$39
Collegium Pharmaceutical, Inc.2$37
Jazz Pharmaceuticals Inc.2$29
Mallinckrodt Enterprises LLC2$26
Argenx US, Inc.1$25
Upsher-smith Laboratories LLC1$25
Ipsen Biopharmaceuticals, Inc1$24
Aquestive Therapeutics, Inc.1$23
Promius Pharma LLC1$22
Corium, LLC1$22
Neurocrine Biosciences, Inc.1$20
Octapharma USA, Inc.1$20
Xeris Pharmaceuticals, Inc.1$20
Otsuka America Pharmaceutical, Inc.1$19
Akcea Therapeutics, Inc.1$18
Zogenix Inc.1$18
Scilex Pharmaceuticals Inc.1$17
Almatica Pharma LLC1$16
Catalyst Pharmaceuticals, Inc.1$15
Bausch Health US, LLC1$14
Arbor Pharmaceuticals, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,399 in reported general payments places this provider in the 70th percentile of 474 neurology providers in Virginia.

See all neurology providers in Virginia

Medicare billing

Part B allowed, 2024
$81,857
Medicare patients
402
Services billed
709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →